323 related articles for article (PubMed ID: 24844163)
21. Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery.
Fan W; Xia D; Zhu Q; Li X; He S; Zhu C; Guo S; Hovgaard L; Yang M; Gan Y
Biomaterials; 2018 Jan; 151():13-23. PubMed ID: 29055774
[TBL] [Abstract][Full Text] [Related]
22. Modified nanoparticles with cell-penetrating peptide and amphipathic chitosan derivative for enhanced oral colon absorption of insulin: preparation and evaluation.
Guo F; Zhang M; Gao Y; Zhu S; Chen S; Liu W; Zhong H; Liu J
Drug Deliv; 2016 Jul; 23(6):2003-14. PubMed ID: 26181840
[TBL] [Abstract][Full Text] [Related]
23. Microfluidic Assembly of a Multifunctional Tailorable Composite System Designed for Site Specific Combined Oral Delivery of Peptide Drugs.
Araújo F; Shrestha N; Shahbazi MA; Liu D; Herranz-Blanco B; Mäkilä EM; Salonen JJ; Hirvonen JT; Granja PL; Sarmento B; Santos HA
ACS Nano; 2015 Aug; 9(8):8291-302. PubMed ID: 26235314
[TBL] [Abstract][Full Text] [Related]
24. Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery.
Su FY; Lin KJ; Sonaje K; Wey SP; Yen TC; Ho YC; Panda N; Chuang EY; Maiti B; Sung HW
Biomaterials; 2012 Mar; 33(9):2801-11. PubMed ID: 22243802
[TBL] [Abstract][Full Text] [Related]
25. Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin.
Sajeesh S; Bouchemal K; Marsaud V; Vauthier C; Sharma CP
J Control Release; 2010 Nov; 147(3):377-84. PubMed ID: 20727924
[TBL] [Abstract][Full Text] [Related]
26. Surface modified porous silicon with chitosan coating as a pH-responsive controlled delivery system for lutein.
Li W; Liu D; Song L; Li H; Dai S; Su Y; Li Q; Li J; Zheng T
Food Funct; 2022 Jun; 13(11):6129-6138. PubMed ID: 35579219
[TBL] [Abstract][Full Text] [Related]
27. New times, new trends for ethionamide: In vitro evaluation of drug-loaded thermally carbonized porous silicon microparticles.
Vale N; Mäkilä E; Salonen J; Gomes P; Hirvonen J; Santos HA
Eur J Pharm Biopharm; 2012 Jun; 81(2):314-23. PubMed ID: 22418076
[TBL] [Abstract][Full Text] [Related]
28. Protein delivery based on uncoated and chitosan-coated mesoporous silicon microparticles.
Pastor E; Matveeva E; Valle-Gallego A; Goycoolea FM; Garcia-Fuentes M
Colloids Surf B Biointerfaces; 2011 Dec; 88(2):601-9. PubMed ID: 21855304
[TBL] [Abstract][Full Text] [Related]
29. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
30. Electrostatic Self-Assembled Chitosan-Pectin Nano- and Microparticles for Insulin Delivery.
Maciel VBV; Yoshida CMP; Pereira SMSS; Goycoolea FM; Franco TT
Molecules; 2017 Oct; 22(10):. PubMed ID: 29023400
[TBL] [Abstract][Full Text] [Related]
31. Enhanced in vitro permeation of furosemide loaded into thermally carbonized mesoporous silicon (TCPSi) microparticles.
Kaukonen AM; Laitinen L; Salonen J; Tuura J; Heikkilä T; Limnell T; Hirvonen J; Lehto VP
Eur J Pharm Biopharm; 2007 Jun; 66(3):348-56. PubMed ID: 17240128
[TBL] [Abstract][Full Text] [Related]
32. Microfluidic Nanoassembly of Bioengineered Chitosan-Modified FcRn-Targeted Porous Silicon Nanoparticles @ Hypromellose Acetate Succinate for Oral Delivery of Antidiabetic Peptides.
Martins JP; Liu D; Fontana F; Ferreira MPA; Correia A; Valentino S; Kemell M; Moslova K; Mäkilä E; Salonen J; Hirvonen J; Sarmento B; Santos HA
ACS Appl Mater Interfaces; 2018 Dec; 10(51):44354-44367. PubMed ID: 30525379
[TBL] [Abstract][Full Text] [Related]
33. Bioinspired zwitterionic polyphosphoester modified porous silicon nanoparticles for efficient oral insulin delivery.
Rao R; Liu X; Li Y; Tan X; Zhou H; Bai X; Yang X; Liu W
Biomater Sci; 2021 Feb; 9(3):685-699. PubMed ID: 33330897
[TBL] [Abstract][Full Text] [Related]
34. Nicotine-magnesium aluminum silicate microparticle surface modified with chitosan for mucosal delivery.
Kanjanakawinkul W; Rades T; Puttipipatkhachorn S; Pongjanyakul T
Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1727-36. PubMed ID: 23827630
[TBL] [Abstract][Full Text] [Related]
35. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
[TBL] [Abstract][Full Text] [Related]
36. Controlled Dissolution of Griseofulvin Solid Dispersions from Electrosprayed Enteric Polymer Micromatrix Particles: Physicochemical Characterization and in Vitro Evaluation.
Roine J; Kaasalainen M; Peurla M; Correia A; Araújo F; Santos HA; Murtomaa M; Salonen J
Mol Pharm; 2015 Jul; 12(7):2254-64. PubMed ID: 26035734
[TBL] [Abstract][Full Text] [Related]
37. Mutlifunctional nanoparticles prepared from arginine-modified chitosan and thiolated fucoidan for oral delivery of hydrophobic and hydrophilic drugs.
Chen CH; Lin YS; Wu SJ; Mi FL
Carbohydr Polym; 2018 Aug; 193():163-172. PubMed ID: 29773368
[TBL] [Abstract][Full Text] [Related]
38. Chitosan nanoparticle antigen uptake in epithelial monolayers can predict mucosal but not systemic in vivo immune response by oral delivery.
Cole H; Bryan D; Lancaster L; Mawas F; Vllasaliu D
Carbohydr Polym; 2018 Jun; 190():248-254. PubMed ID: 29628245
[TBL] [Abstract][Full Text] [Related]
39. Hydrocaffeic acid-chitosan nanoparticles with enhanced stability, mucoadhesion and permeation properties.
Soliman GM; Zhang YL; Merle G; Cerruti M; Barralet J
Eur J Pharm Biopharm; 2014 Nov; 88(3):1026-37. PubMed ID: 25281213
[TBL] [Abstract][Full Text] [Related]
40. Alendronate-loaded microparticles for improvement of intestinal cellular absorption.
Baek JS; Kwon HH; Hwang JS; Sung HC; Lee JM; Shin SC; Kim YR; Cho CW
J Drug Target; 2011 Jan; 19(1):37-48. PubMed ID: 20477555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
